Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nanobiotix S.A. ADR (NQ: NBTX ) 4.160 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nanobiotix S.A. ADR < Previous 1 2 3 4 5 6 7 8 9 Next > Why is Trupanion (TRUP) Stock Down 32% Today? May 05, 2023 Trupanion (TRUP) stock is taking a beating on Friday after the pet medical insurance company released its earnings report for Q1 2023. Via InvestorPlace 12 Health Care Stocks Moving In Friday's Pre-Market Session May 05, 2023 Via Benzinga Why Is Galmed Pharmaceuticals (GLMD) Stock Up 37% Today? May 05, 2023 Galmed Pharmaceuticals (GLMD) stock is gaining on Friday after the company announced an investment agreement with OnKai. Via InvestorPlace Why is Nanobiotix (NBTX) Stock Up 107% Today? May 05, 2023 Nanobiotix (NBTX) stock is taking off on Friday after the company revealed details about ongoing contract negotiations for NBTXR3. Via InvestorPlace Why Carvana Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket May 05, 2023 Gainers Via Benzinga Why Are Nanobiotix Shares Plummeting Today? April 25, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday May 05, 2023 Good morning! We're diving into the biggest pre-market stock movers traders will want to keep an eye on for Friday morning! Via InvestorPlace NANOBIOTIX Entering Final Contract Negotiations Following Agreement to Non-Binding Term Sheet for Development and Commercialization of NBTXR3 With a Major Global Pharmaceutical Company May 05, 2023 Company agreed to term sheet as of May 3, 2023 From Nanobiotix S.A. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session April 27, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session April 27, 2023 Via Benzinga Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 25, 2023 Gainers Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 25, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 25, 2023 Via Benzinga NANOBIOTIX Provides Business Update and Reports Full Year 2022 Financial Results April 24, 2023 From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX to Provide Operational Update and Report Full Year 2022 Financial Results on April 24, 2023 April 17, 2023 From Nanobiotix S.A. Via GlobeNewswire Voting Rights and Shares Capital of the Company April 11, 2023 From Nanobiotix S.A. Via GlobeNewswire Earnings Scheduled For April 24, 2023 April 24, 2023 Companies Reporting Before The Bell • Dynex Cap (NYSE:DX) is estimated to report quarterly earnings at $0.17 per share on revenue of $6.99 million. Via Benzinga Nanobiotix to Postpone Full Year 2022 Financial Results and Conference Call March 27, 2023 From Nanobiotix S.A. Via GlobeNewswire Nanobiotix to Provide Operational Update and Report Full Year 2022 Financial Results on March 28, 2023 March 14, 2023 From Nanobiotix S.A. Via GlobeNewswire Voting Rights and Shares Capital of the Company February 14, 2023 In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) From Nanobiotix S.A. Via GlobeNewswire Voting Rights and Shares Capital of the Company January 11, 2023 In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX Announces First Patient Randomized in the United States in Global Phase 3 Pivotal Trial Evaluating Radioenhancer NBTXR3 in Head and Neck Cancer December 27, 2022 From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX Announces Termination of Liquidity Contract and Publishes End of Contract Statement December 21, 2022 From Nanobiotix S.A. Via GlobeNewswire Voting Rights and Shares Capital of the Company December 08, 2022 From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX to Present at the 5th Annual Evercore ISI HealthCONx Conference November 15, 2022 From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX Announces Recommended Phase 2 Dose for NBTXR3 in Pancreatic Cancer November 14, 2022 From Nanobiotix S.A. Via GlobeNewswire Nanobiotix Posts Updated Data For Radiotherapy-Activated Cancer Therapy In Head & Neck Cancer Patients November 10, 2022 Via Benzinga NANOBIOTIX Reports Updated Phase 1 Anti-PD-1 Combination Data That May Support the Immune Stimulation Potential of Radioenhancer NBTXR3 at the 37th Annual Meeting of the Society for Immunotherapy of Cancer November 10, 2022 Data to be discussed during Nanobiotix Q3 Earnings Call at 8:00AM EST From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX Provides Third Quarter 2022 Operational and Financial Update November 09, 2022 From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX Voting Rights and Shares Capital of the Company November 08, 2022 From Nanobiotix S.A. Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
